Retatrutide is investigational, so there is no pharmacy quality gate between the manufacturer and you — a point covered in the US access guide. That single fact reframes the whole purchase: you are not buying a vial of powder, you are buying a set of measurements about that powder. If you can't read those measurements, you are buying on faith. This is the technical guide to reading them well.
It is written for research and educational purposes. Everything here describes analytical standards and how to interpret supplier documentation; none of it is medical advice, and retatrutide is not approved for human use.
What to actually verify before buying retatrutide
Before the section-by-section detail, here is the whole checklist in one view — each quality signal, the concrete thing to check for it, and the red flag that should stop you.
| Quality signal | What to check | Red flag |
|---|---|---|
| Identity | Mass spectrometry confirms the measured mass matches retatrutide [5] | No identity test — only a purity number |
| Purity | Measured by HPLC, reported as a number tied to a lot [1] | A claim ("99%+") with no chromatogram or method |
| Impurity profile | The non-target fraction is characterized, not just measured [4] | A purity figure with no impurity breakdown |
| Lot match | The COA's lot number matches the vial label | A generic catalog spec sheet reused for every batch |
| Endotoxin | Tested per USP <85> (LAL), reported in EU/mg [2] | "Sterile" claimed with no endotoxin data |
| Sterility | Tested per USP <71> where sterility is claimed [3] | Sterility asserted, never tested |
| Independence | An independent third-party lab re-ran the numbers | Only the manufacturer's own testing available |
| Transparency | The supplier volunteers all of this | You have to pry the documentation loose |
The rest of this guide unpacks each row: what the test is, what it proves, and how to tell a real result from theater. The order matters — identity before purity, purity before contamination — because a high purity number is meaningless if the molecule isn't retatrutide in the first place.
What a certificate of analysis (COA) is — and why it's the whole game
A certificate of analysis is a lab document that reports the measured properties of one specific production lot: what the molecule is, how pure it is, and what the impurities are. The emphasis on one specific lot is the entire point. Peptide quality varies batch to batch — synthesis, purification, and lyophilization all introduce run-to-run variation — so a document that isn't tied to the lot in your hand tells you nothing about the vial you received.
This is the most common sleight of hand in the research-compound market: a generic catalog spec sheet dressed up to look like a COA. It lists a compound, a target purity, maybe a molecular formula — but no lot number, no measured values, no chromatogram, no date. It is a marketing document. A real COA is a measurement record for a specific batch, signed and dated, that you can tie to the label on your vial.
If the only document a supplier can produce looks like the left column, you don't yet have enough to buy. Everything below is how to evaluate the right column.
How to read a retatrutide COA line by line
Once you have a genuine, lot-specific COA in front of you, read it in a fixed order. Each line answers a different question, and they build on each other.
| Line item | The question it answers | What "good" looks like |
|---|---|---|
| Product + lot number | Is this document about my vial? | Lot matches the vial label exactly |
| Molecular formula / mass | What should the molecule weigh? | Retatrutide's theoretical mass is stated |
| Identity (MS) | Is it actually retatrutide? | Measured mass matches theoretical [5] |
| Purity (HPLC) | How much is the target compound? | A measured %, with the HPLC method noted [1] |
| Impurity profile | What is the rest? | Named/characterized, not blank [4] |
| Appearance / content | Right form and fill? | Lyophilized powder, stated mg per vial |
| Endotoxin / sterility | Is it contaminated? | Reported where sterility is claimed [2] [3] |
| Date + signature | Is it a real, current record? | Signed, dated, tied to the lot |
The two lines people skip are the two that matter most. Identity is the yes/no question — is this molecule retatrutide at all? — and it can only be answered by mass spectrometry, never by a purity number. Impurity profile is the honesty check: a supplier who reports a purity figure but leaves the impurity section blank is telling you they measured how much target compound is present but never asked what the rest is.
Third-party HPLC and mass-spec testing: what each method proves
"Tested" is not one thing. Two different analytical methods answer two different questions, and a real COA carries both. Confusing them — treating a purity number as proof of identity, or vice versa — is the most common way a buyer talks themselves into a bad lot.
Mass spectrometry ionizes the sample and measures its mass-to-charge ratio, letting the lab confirm the measured molecular mass matches retatrutide's theoretical mass. This is the test that catches a substituted or mislabeled peptide — a different compound can be sold as "retatrutide," but it cannot fake its molecular weight under MS. Identity confirmation by an appropriate physicochemical method is a core specification for a peptide of this class. [5]
HPLC (high-performance liquid chromatography) pushes the sample through a column that separates its components by how they interact with the stationary phase; a detector then records each as a peak. The area under the main peak, relative to the total, is the purity figure — and the smaller peaks are the impurities. HPLC purity determination is a standardized chromatographic method. [1] The reason "third-party" matters is that the same sample re-run at an independent lab — not the manufacturer's — is the only version of these numbers that can be audited. A manufacturer's own COA is a starting point, not a verdict; our full reasoning is in how we vet a new manufacturer.
What purity threshold actually matters (and why 99% isn't the whole story)
Research-grade peptides are commonly specified at ≥98–99% by HPLC, and that is a reasonable bar to expect. But the headline percentage is where naive buyers stop and careful buyers start. The real question is what sits in the remaining fraction.
Impurity-qualification guidance exists precisely because "how much" is a different question from "what is it." Under ICH Q3A(R2), impurities in a drug substance are handled against thresholds tied to daily dose: a reporting threshold, an identification threshold (commonly around 0.1%), and a qualification threshold. [4] The practical translation for a buyer: individual impurities above roughly the tenth-of-a-percent level are supposed to be identified, not just counted. A COA that reports "99% pure" and stops has answered the easy half.
So read the purity line and the impurity line together. A characterized 1% of a known, process-related impurity is exactly what a clean synthesis looks like. An uncharacterized 1% the supplier can't name means the number on top is describing a product no one has fully identified.
Endotoxin and sterility: the tests people forget to ask about
Purity tells you what fraction is retatrutide. It says nothing about biological contamination — and for peptide research that distinction is easy to miss and expensive to ignore.
Endotoxins are heat-stable fragments of Gram-negative bacterial cell walls. They are potent pyrogens, they survive ordinary sterilization, and they are invisible to a purity assay — a lot can be 99% pure by HPLC and still carry an endotoxin load that confounds any biological readout. The standard test is the Limulus Amebocyte Lysate (LAL) assay, described in USP General Chapter <85>, which reports contamination in endotoxin units (EU). [2]
Sterility is the separate question of whether viable microorganisms are present, tested per USP General Chapter <71>. [3] Not every research lyophilized powder is sold as sterile — but if a supplier claims sterility, that claim should be backed by an actual USP <71> result, not asserted on the label. The tell is simple: a source that says "sterile" and can't produce the test has given you a marketing word, not a measurement.
Batch testing vs one-time testing: why the lot matters
A single clean COA proves one batch was clean once. It does not prove the supplier's process is reliable, and process reliability is what you are actually paying for when you buy more than one vial.
This is why lot-specific documentation is non-negotiable and why the strongest suppliers test every lot rather than testing one batch and reusing its certificate. Peptide synthesis is not perfectly reproducible run to run; the whole reason a COA is tied to a lot number is that the previous lot's numbers don't transfer to this one. When you evaluate a source, the question isn't only "is this COA good," it's "does a new COA exist for every new lot." A supplier who tests once and coasts is selling you the reputation of a batch you'll never receive.
Internally, our own standard goes a step further than a single passing test — we require repeated independent testing across separate lots before a manufacturer is added at all, which is the full subject of how we vet a new manufacturer.
"Research use only," legality, and what it means for a buyer
Because retatrutide is investigational, it is supplied "for research use only" (RUO) — for laboratory and in-vitro study — not as a medication. This phrase is widely misread, so it is worth stating precisely: RUO is a description of what the product is and how it is regulated, not a loophole that quietly permits human use. The material is explicitly not intended, tested, or approved for administration to people.
For a buyer, the practical consequence is the one this whole guide is built around: there is no regulator checking each batch, so the documentation is the quality system. That is not a reason to avoid the market — it is the reason to learn to read it. The access guide covers the legal framing in more depth; here the point is narrower. RUO means the burden of verification sits with you, and the tools for meeting it are the COA, the analytical methods above, and independent testing.
Red flags of a low-quality retatrutide supplier
Most bad sources reveal themselves in the documentation before anything ships. These are the tells that should end a purchase — each one is a place where a real quality process would have left a mark and didn't.
- No lot-specific COA — only a generic spec sheet, or a purity claim with no measurement document behind it.
- A purity number with no method and no chromatogram. "99%+" printed on a page is a claim; a purity figure is a measured peak area from a named HPLC method. [1]
- Identity never established. A COA with purity but no mass-spec identity has never confirmed the molecule is retatrutide. [5]
- A blank impurity profile. A high purity figure with nothing said about the remaining fraction. [4]
- "Sterile" with no endotoxin or sterility data to back the claim. [2] [3]
- Only the manufacturer's own numbers, with no independent verification available.
- A price far below the field. Independent testing across lots costs money; a rock-bottom price usually means that verification was the corner that got cut.
- Evasiveness. A supplier reluctant to send documentation for the exact lot you'll receive is answering the question.
Questions to ask a supplier before you order
A few direct questions sort transparent suppliers from evasive ones fast. Frame them around the methods, not just the paperwork — a real source answers all of these without friction.
- Can I see the COA for the specific lot I'll receive — not a representative or catalog one?
- Was identity confirmed by mass spectrometry, and does the measured mass match retatrutide's? [5]
- Was purity measured by HPLC, and can I see the method and the value? [1]
- Is the impurity profile characterized — can you tell me what the non-target fraction is? [4]
- Where sterility is claimed, do you have USP <85> endotoxin and USP <71> sterility results? [2] [3]
- Was any of this verified by an independent third-party lab, or only your own?
- Do you test every lot, or only occasionally?
The specific answers matter, but the willingness to answer matters more. A supplier who treats these as reasonable is showing you their process; one who deflects is showing you something too.
Storage and handling the moment your vial arrives
A perfect COA describes the vial that left the lab. Whether it's still a quality input by the time you use it depends on what happens after it arrives — and this is where careful buyers protect the money they spent on verification.
Retatrutide ships as a lyophilized (freeze-dried) powder because dry peptide is far more stable than peptide in solution. Kept cold and dark, the lyophilized form is comparatively robust; left warm on a doorstep or in a car, it starts losing the integrity the COA certified. Once reconstituted with bacteriostatic water, the clock speeds up: the peptide is now in solution, so it is refrigerated, dated, and handled gently — added slowly down the vial wall, swirled, never shaken. The full procedure is in how to reconstitute peptides with bacteriostatic water. The point for a buyer is that handling is part of quality control, not separate from it: sloppy storage quietly turns a verified vial into an unknown one.
How to verify a source is legit: a repeatable process
Put together, evaluating a retatrutide source is a short, repeatable routine — run it the same way every time and treat it as the first experiment, before any real experiment starts.
- Get the lot-specific COA for the exact vial you'll receive, and confirm the lot number matches.
- Check identity first — mass spectrometry, measured mass against theoretical. [5]
- Then purity — an HPLC-measured number with the method shown. [1]
- Read the impurity profile — is the non-target fraction characterized? [4]
- Check contamination where sterility is claimed — endotoxin (USP <85>) and sterility (USP <71>). [2] [3]
- Confirm independence — did a third-party lab stand behind the numbers?
- Confirm it's per-lot — does a fresh COA exist for every batch, not one reused certificate?
A source that clears all seven is transparent in exactly the ways a bad source can't fake. Modern Bio's retatrutide ships with a batch-matched COA on every vial — the standard this checklist describes, applied to our own supply. For the compound itself — mechanism, trial data, and dosing — see the complete retatrutide guide.
Frequently asked questions
- How do I know if retatrutide is real and not fake?
- Verify identity and purity on a batch-matched certificate of analysis — identity confirmed by mass spectrometry (the measured mass matches retatrutide's molecular weight), purity measured by HPLC as a number tied to a specific lot, and a characterized impurity profile. Identity by mass spec is the single test that distinguishes real retatrutide from a mislabeled or substituted peptide.
- What is a certificate of analysis (COA) for retatrutide?
- A COA is a lab document reporting the measured identity and purity of one specific production lot — mass by HPLC, identity by mass spectrometry, a measured purity percentage, and an impurity profile. A valid COA carries a lot number that matches the vial you receive; a generic catalog spec sheet reused across every batch is not a COA.
- What purity should retatrutide be?
- Reputable research-grade peptides are typically specified at ≥98–99% by HPLC, but the percentage alone is incomplete. Under impurity-qualification guidance (ICH Q3A), impurities above roughly a 0.1% identification threshold should be identified, so a characterized impurity profile matters as much as the headline number — a known 1% is a very different product than an unidentified 1%.
- What is endotoxin testing and why does it matter for peptides?
- Endotoxin (bacterial pyrogen) testing measures contamination from Gram-negative bacteria using the LAL assay described in USP <85>. It matters because endotoxin survives sterilization and can confound any biological readout. USP sets the threshold pyrogenic dose for parenteral products at 5 EU/kg per hour, which is the basis for a batch endotoxin limit.
- How can I verify a retatrutide supplier is legit?
- Ask for the COA for the exact lot you will receive, confirm identity was done by mass spectrometry and purity by HPLC, ask whether an independent third-party lab verified it, and ask whether every lot is tested or only occasionally. A transparent supplier answers all four without friction; evasiveness is itself the answer.
- How should I store retatrutide when it arrives?
- Lyophilized (freeze-dried) retatrutide is far more stable than peptide in solution and is typically stored cold and dark until use; once reconstituted with bacteriostatic water it is refrigerated and dated. Even a perfect vial degrades if it is left warm or reconstituted carelessly, so handling on arrival is part of quality control, not an afterthought.
Glossary
- Certificate of Analysis (COA)
- A lab document reporting the measured identity and purity of a specific production lot — the core quality record for a research compound.
- HPLC
- High-performance liquid chromatography — separates and quantifies the main compound and its impurities to measure purity as a peak-area percentage.
- Mass spectrometry (MS)
- An analytical method that confirms molecular identity by measuring mass-to-charge ratio; the test that verifies a peptide is what the label claims.
- Impurity profile
- Characterization of the non-target fraction of a sample — what the impurities actually are, not just how much.
- Identification threshold
- Under ICH Q3A, the level (commonly ~0.1%) above which an individual impurity in a drug substance should be identified rather than only counted.
- Endotoxin (LAL) test
- The Limulus Amebocyte Lysate assay (USP <85>) that measures pyrogenic contamination from Gram-negative bacteria, reported in endotoxin units (EU).
- Sterility test
- USP <71> testing for the presence of viable microorganisms — the basis for any legitimate sterility claim.
- Research use only (RUO)
- Material supplied for laboratory/in-vitro study, explicitly not intended, tested, or approved for human use.
- Lot / batch
- A single production run. Batch-specific documentation ties every quality claim to the vial you actually receive.
References
- United States Pharmacopeia (USP). General Chapter <621> Chromatography — HPLC purity determination methods.
- United States Pharmacopeia (USP). General Chapter <85> Bacterial Endotoxins Test — LAL assay and the 5 EU/kg threshold pyrogenic dose for parenteral products.
- United States Pharmacopeia (USP). General Chapter <71> Sterility Tests.
- ICH Q3A(R2). Impurities in New Drug Substances — International Council for Harmonisation guideline on reporting, identification, and qualification thresholds for impurities.
- ICH Q6B. Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products — identity and purity specifications for peptide-class substances.
For research and educational purposes only. Not medical advice. This guide describes analytical standards and how to evaluate supplier documentation; it does not instruct anyone to self-administer. Retatrutide is investigational and is not approved for human use.